Advanov Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.10 M
as on 11-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 11-07-2024
- Revenue 34.60%
(FY 2022)
- Profit 39.78%
(FY 2022)
- Ebitda -88.27%
(FY 2022)
- Net Worth 129.08%
(FY 2022)
- Total Assets 270.55%
(FY 2022)
About Advanov Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 Cr.
Hemalkumar Shah and Gayatriben Shah serve as directors at the Company.
- CIN/LLPIN
U74999GJ2017PTC097840
- Company No.
097840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Advanov Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemalkumar Shah  | Managing Director | 18-Apr-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gayatriben Shah | Director | 06-Feb-2023 | Current |
Financial Performance of Advanov Pharma.
Advanov Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.6% increase. The company also saw a substantial improvement in profitability, with a 39.78% increase in profit. The company's net worth Soared by an impressive increase of 129.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanov Pharma?
Unlock access to Advanov Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Jewal Pharmaceutical Private LimitedActive 3 years 7 days
Hemalkumar Shah and Gayatriben Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 26 Mar 2021 | ₹2.50 Cr | Open |
How Many Employees Work at Advanov Pharma?
Unlock and access historical data on people associated with Advanov Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanov Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanov Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
